Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine Combinations in Elderly SCLC
NCT00401609Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2000
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in small cell lung cancer (SCLC), sponsored by National Cancer Institute. Started Nov 2000; status: completed.
02
Drugs
gemcitabine
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00401609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401609.